[1] 檀玉芬,闫惠平,赵艳,等.丙型肝炎和自身免疫性肝炎自身抗体的特点分析.中国实验诊断学,2007,11:622-625.
[2] 中华医学会肝病学分会,中华医学会感染病学分会.丙型肝炎防治指南(2015 年更新版).临床肝胆病杂志,2015,31:1961-1979.
[3] 陈思如,韦嘉.HCV 感染者自身抗体的研究进.医学综述,2014,20:3503-3505.
[4] 陈赞潘,修成.丙型肝炎与自身免疫性疾病.中华肝脏病杂志,2006,14:236-237.
[5] 周厚清, 董敏.丙型肝炎患者血清自身抗体检测的临床研究.中国卫生检验杂志,2009,19:131-132.
[6] 吴赤红,徐小元,田庚善,等.慢性丙型肝炎患者血清自身抗体检测的研究.中华医学杂志, 2006, 86: 390 -393.
[7] 王春妍,胡东胜.天津地区慢性丙型肝炎患者自身抗体检测结果及临床分析. 肝脏,2010, 15:314-315.
[8] Agmonlevin N, Ram M, Barzilai O, et al. Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun, 2009, 32:261-266.
[9] Kammer AR, van der Burg SH, Grabscheid B, et al. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J Exp Med, 1999, 190:169-176.
[10] García-Carrasco M, Font Franco J, Ingelmo Morín M, et al. Clinical manifestations and immunology associated with chronic infection with hepatitis C virus. Rev Clin Esp, 2002, 202:224-232. |
